1.Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
Sheng-Li YANG ; Quan-Guang REN ; Lu WEN ; Jian-Li HU
Journal of Huazhong University of Science and Technology (Medical Sciences) 2016;36(3):321-327
Hypoxia-inducible factor-1 alpha (HIF-1α) plays a vital role in the initiation, evaluation and prognosis in lung cancer. The prognostic value of HIF-1α reported in diverse study remains disputable. Accordingly, a meta-analysis was implemented to further understand the prognostic role of HIF-1α in lung cancer. The relationship between HIF-1α and the clinicopathological characteristics and prognosis of lung cancer were investigated by a meta-analysis. PubMed and Embase were searched from their inception to January 2015 for observational studies. Fixed-effects or random-effects meta-analyses were used to calculate odds ratios and 95% confidence intervals of different comparisons. A total of 20 studies met the criteria. The results showed that HIF-1α expression in lung cancer tissues was significantly higher than that in normal lung tissues. Expression of HIF-1α in patients with squamous cell carcinoma was significantly higher than that of patients with adenocarcinomas. Similarly, non-small cell lung cancer (NSCLC) patients had higher HIF-1α expression than small cell lung cancer (SCLC) patients. Moreover, lymph node metastasized tissues had higher HIF-1α expression than non-lymph node metastasized tissues. A high level HIF-1α expression was well correlated with the expression of vascular endothelial growth factor and epidermal growth factor receptor in the NSCLC. Notably, NSCLC or SCLC patients with positive HIF-1α expression in tumor tissues had lower overall survival rate than patients with negative HIF-1α expression. It was suggested that HIF-1α expression may be a prognostic biomarker and a potential therapeutic target for lung cancer.
Adenocarcinoma
;
diagnosis
;
genetics
;
mortality
;
pathology
;
Biomarkers, Tumor
;
genetics
;
metabolism
;
Carcinoma, Non-Small-Cell Lung
;
diagnosis
;
genetics
;
mortality
;
pathology
;
Carcinoma, Squamous Cell
;
diagnosis
;
genetics
;
mortality
;
pathology
;
Humans
;
Hypoxia-Inducible Factor 1, alpha Subunit
;
genetics
;
metabolism
;
Lung Neoplasms
;
diagnosis
;
genetics
;
mortality
;
pathology
;
Lymphatic Metastasis
;
Neoplasm Grading
;
Neoplasm Staging
;
Odds Ratio
;
Prognosis
;
Receptor, Epidermal Growth Factor
;
genetics
;
metabolism
;
Survival Analysis
;
Vascular Endothelial Growth Factor A
;
genetics
;
metabolism
2.Thyroid Transcription Factor-1 (TTF-1) Expression in Human Lung Carcinomas: Its Prognostic Implication and Relationship with Expressions of p53 and Ki-67 Proteins.
Journal of Korean Medical Science 2003;18(4):494-500
This study was aimed to evaluate the prevalence and prognostic implication of thyroid transcription factor-1 (TTF-1) immunoreactivity in 81 human lung carcinomas, including 65 cases of non-small cell lung carcinoma (NSCLC) and 16 cases of small cell lung carcinoma (SCLC); and also to investigate its relationship with the cell proliferation and regulation by immunostaining of Ki-67 and p53 proteins, respectively. The immunohistochemical staining for TTF-1(clone 8G7G3/1) was performed and several clinicopathologic variables and the follow-up data were obtained. The immuno-staining results for TTF-1 were semiquantitatively interpreted as negative and positive. Of NSCLCs, TTF-1 is highly expressed in adenocarcinomas (76%), whereas squamous cell carcinomas revealed no immunoreactivity (0%). SCLCs showed strong TTF-1 expression (88%). In NSCLC, TTF-1 expression was inversely correlated with Ki-67 proliferative activity and independent of p53 overexpression. TTF-1(+) group tended to show better survival than TTF-1(-) group in NSCLC. Conclusively, these observations suggest that TTF-1 is a sensitive and specific diagnostic marker for pulmonary adenocarcinomas and SCLCs; that TTF-1 might have a good prognostic implication based on its inverse correlation with Ki-67 proliferative activity and tendency for better survival in NSCLC; that this cell lineage marker may play a role in the molecular pathogenesis of lung cancers at the level of transcription.
Adenocarcinoma/diagnosis/metabolism
;
Adult
;
Aged
;
Carcinoma, Non-Small-Cell Lung/diagnosis/*metabolism/mortality
;
Carcinoma, Small Cell/diagnosis/*metabolism/mortality
;
Cell Division
;
Cell Line, Tumor
;
Cell Lineage
;
Female
;
Human
;
Immunohistochemistry
;
Ki-67 Antigen/*biosynthesis
;
Lung Neoplasms/diagnosis/*metabolism/mortality
;
Male
;
Middle Aged
;
Nuclear Proteins/*biosynthesis
;
Prognosis
;
Protein p53/*biosynthesis
;
Sensitivity and Specificity
;
Time Factors
;
Transcription Factors/*biosynthesis
;
Transcription, Genetic
;
Tumor Markers, Biological
3.The Prognostic Impact of Heat Shock Proteins Expression in Patients with Esophageal Cancer: A Meta-Analysis.
Xiao Wei WANG ; Xin Hui SHI ; Yu Suo TONG ; Xiu Feng CAO
Yonsei Medical Journal 2015;56(6):1497-1502
PURPOSE: Heat shock proteins (HSPs) are highly conserved molecular chaperones. There are various studies that assess the prognostic value of HSPs in patients with esophageal cancer, but the conclusion remains controversial. This is the first meta-analysis study aiming to summarize the evidence on the suitability of HSPs to predict patients' survival. MATERIALS AND METHODS: Searching PubMed, Web of science and Medline until May 31, 2014, data were compared for overall survival in patients with down-regulated HSPs level with those with up-regulated level. We conducted a meta-analysis of 9 studies (801 patients) that correlated HSPs levels with overall survival. Data were synthesized with hazard ratios (HRs). RESULTS: The estimated risk of death was 2.93-fold greater in HSP27 negative patients than HSP27 positive patients [95% confidence interval (CI), 1.12-7.62]. When limited to esophageal squamous cell carcinoma (ESCC), the risk of death in HSP27 negative patients seemed more significant (HR, 3.90; 95% CI, 2.35-6.49). Decreased expression of HSP70 was also associated with worse survival in esophageal cancer (HR, 2.83; 95% CI, 1.90-4.23) and, when limited to ESCC, HR was 3.21 (95% CI, 1.94-5.30). Data collected, however, were not sufficient to determine the prognostic value of HSP90 in patients with ESCC nor esophageal adenocarcinomas (EADC). CONCLUSION: In this meta-analysis, reduced HSP27 and HSP70 expressions were associated with poor survival in patients with esophageal cancer, especially esophageal squamous cell carcinoma.
Adenocarcinoma/*diagnosis/*metabolism/mortality
;
Carcinoma, Squamous Cell/diagnosis/*metabolism/therapy
;
Esophageal Neoplasms/*diagnosis/*metabolism/mortality/therapy
;
Gene Expression Regulation, Neoplastic
;
HSP27 Heat-Shock Proteins
;
HSP70 Heat-Shock Proteins
;
HSP90 Heat-Shock Proteins
;
Heat-Shock Proteins/*metabolism
;
Humans
;
Male
;
Neoplasm Proteins
;
Prognosis
;
Survival
;
Treatment Outcome